CD44 and glioblastoma: To examine whether CD44 expression in the tumor periphery offers a useful marker to predict invasiveness of GBM, the relationship between P/C ratio of CD44 expression and tumor invasiveness as evaluated by spectroscopic 5-ALA fluorescence intensity was investigated.